Global Medical Monitoring Services 麻豆原创 Research Report 2025

Publication ID:

PB503255652

Publication Date:

March 4, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Medical Monitoring Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Medical Monitoring Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Monitoring Services.
The Medical Monitoring Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Monitoring Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Monitoring Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Pharm-Olam
Veristat
ProPharma Group
George Clinical
CRO
Rho, Inc.
CROMSOURCE
SGS
TFS HealthScience
Southern Star Research
Navitas Life Sciences
Celerion
Boyds
eClinical Solutions
Segment by Type
Inclusion/exclusion Criteria Issues
Protocol Exemptions and Deviations
Medical Crisis Monitoring
Medication Issues
Laboratory Findings
SAE Reporting
Others
Segment by Application
Biotechnology and Pharmaceuticals
Contract Research Organization
Hospital
KPO / BPO
Healthcare Institutions
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Monitoring Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Medical Monitoring Services 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Inclusion/exclusion Criteria Issues
1.2.3 Protocol Exemptions and Deviations
1.2.4 Medical Crisis Monitoring
1.2.5 Medication Issues
1.2.6 Laboratory Findings
1.2.7 SAE Reporting
1.2.8 Others
1.3 麻豆原创 by Application
1.3.1 Global Medical Monitoring Services 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Monitoring Services 麻豆原创 Perspective (2020-2031)
2.2 Global Medical Monitoring Services Growth Trends by Region
2.2.1 Global Medical Monitoring Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Medical Monitoring Services Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Medical Monitoring Services Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Medical Monitoring Services 麻豆原创 Dynamics
2.3.1 Medical Monitoring Services Industry Trends
2.3.2 Medical Monitoring Services 麻豆原创 Drivers
2.3.3 Medical Monitoring Services 麻豆原创 Challenges
2.3.4 Medical Monitoring Services 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Monitoring Services Players by Revenue
3.1.1 Global Top Medical Monitoring Services Players by Revenue (2020-2025)
3.1.2 Global Medical Monitoring Services Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Medical Monitoring Services 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Medical Monitoring Services Revenue
3.4 Global Medical Monitoring Services 麻豆原创 Concentration Ratio
3.4.1 Global Medical Monitoring Services 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Monitoring Services Revenue in 2024
3.5 Global Key Players of Medical Monitoring Services Head office and Area Served
3.6 Global Key Players of Medical Monitoring Services, Product and Application
3.7 Global Key Players of Medical Monitoring Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Monitoring Services Breakdown Data by Type
4.1 Global Medical Monitoring Services Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Medical Monitoring Services Forecasted 麻豆原创 Size by Type (2026-2031)
5 Medical Monitoring Services Breakdown Data by Application
5.1 Global Medical Monitoring Services Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Medical Monitoring Services Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Medical Monitoring Services 麻豆原创 Size (2020-2031)
6.2 North America Medical Monitoring Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Medical Monitoring Services 麻豆原创 Size by Country (2020-2025)
6.4 North America Medical Monitoring Services 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Monitoring Services 麻豆原创 Size (2020-2031)
7.2 Europe Medical Monitoring Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Medical Monitoring Services 麻豆原创 Size by Country (2020-2025)
7.4 Europe Medical Monitoring Services 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Monitoring Services 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Medical Monitoring Services 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Medical Monitoring Services 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Medical Monitoring Services 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical Monitoring Services 麻豆原创 Size (2020-2031)
9.2 Latin America Medical Monitoring Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Medical Monitoring Services 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Medical Monitoring Services 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Monitoring Services 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Medical Monitoring Services 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Medical Monitoring Services 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Medical Monitoring Services 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharm-Olam
11.1.1 Pharm-Olam Company Details
11.1.2 Pharm-Olam Business Overview
11.1.3 Pharm-Olam Medical Monitoring Services Introduction
11.1.4 Pharm-Olam Revenue in Medical Monitoring Services Business (2020-2025)
11.1.5 Pharm-Olam Recent Development
11.2 Veristat
11.2.1 Veristat Company Details
11.2.2 Veristat Business Overview
11.2.3 Veristat Medical Monitoring Services Introduction
11.2.4 Veristat Revenue in Medical Monitoring Services Business (2020-2025)
11.2.5 Veristat Recent Development
11.3 ProPharma Group
11.3.1 ProPharma Group Company Details
11.3.2 ProPharma Group Business Overview
11.3.3 ProPharma Group Medical Monitoring Services Introduction
11.3.4 ProPharma Group Revenue in Medical Monitoring Services Business (2020-2025)
11.3.5 ProPharma Group Recent Development
11.4 George Clinical
11.4.1 George Clinical Company Details
11.4.2 George Clinical Business Overview
11.4.3 George Clinical Medical Monitoring Services Introduction
11.4.4 George Clinical Revenue in Medical Monitoring Services Business (2020-2025)
11.4.5 George Clinical Recent Development
11.5 CRO
11.5.1 CRO Company Details
11.5.2 CRO Business Overview
11.5.3 CRO Medical Monitoring Services Introduction
11.5.4 CRO Revenue in Medical Monitoring Services Business (2020-2025)
11.5.5 CRO Recent Development
11.6 Rho, Inc.
11.6.1 Rho, Inc. Company Details
11.6.2 Rho, Inc. Business Overview
11.6.3 Rho, Inc. Medical Monitoring Services Introduction
11.6.4 Rho, Inc. Revenue in Medical Monitoring Services Business (2020-2025)
11.6.5 Rho, Inc. Recent Development
11.7 CROMSOURCE
11.7.1 CROMSOURCE Company Details
11.7.2 CROMSOURCE Business Overview
11.7.3 CROMSOURCE Medical Monitoring Services Introduction
11.7.4 CROMSOURCE Revenue in Medical Monitoring Services Business (2020-2025)
11.7.5 CROMSOURCE Recent Development
11.8 SGS
11.8.1 SGS Company Details
11.8.2 SGS Business Overview
11.8.3 SGS Medical Monitoring Services Introduction
11.8.4 SGS Revenue in Medical Monitoring Services Business (2020-2025)
11.8.5 SGS Recent Development
11.9 TFS HealthScience
11.9.1 TFS HealthScience Company Details
11.9.2 TFS HealthScience Business Overview
11.9.3 TFS HealthScience Medical Monitoring Services Introduction
11.9.4 TFS HealthScience Revenue in Medical Monitoring Services Business (2020-2025)
11.9.5 TFS HealthScience Recent Development
11.10 Southern Star Research
11.10.1 Southern Star Research Company Details
11.10.2 Southern Star Research Business Overview
11.10.3 Southern Star Research Medical Monitoring Services Introduction
11.10.4 Southern Star Research Revenue in Medical Monitoring Services Business (2020-2025)
11.10.5 Southern Star Research Recent Development
11.11 Navitas Life Sciences
11.11.1 Navitas Life Sciences Company Details
11.11.2 Navitas Life Sciences Business Overview
11.11.3 Navitas Life Sciences Medical Monitoring Services Introduction
11.11.4 Navitas Life Sciences Revenue in Medical Monitoring Services Business (2020-2025)
11.11.5 Navitas Life Sciences Recent Development
11.12 Celerion
11.12.1 Celerion Company Details
11.12.2 Celerion Business Overview
11.12.3 Celerion Medical Monitoring Services Introduction
11.12.4 Celerion Revenue in Medical Monitoring Services Business (2020-2025)
11.12.5 Celerion Recent Development
11.13 Boyds
11.13.1 Boyds Company Details
11.13.2 Boyds Business Overview
11.13.3 Boyds Medical Monitoring Services Introduction
11.13.4 Boyds Revenue in Medical Monitoring Services Business (2020-2025)
11.13.5 Boyds Recent Development
11.14 eClinical Solutions
11.14.1 eClinical Solutions Company Details
11.14.2 eClinical Solutions Business Overview
11.14.3 eClinical Solutions Medical Monitoring Services Introduction
11.14.4 eClinical Solutions Revenue in Medical Monitoring Services Business (2020-2025)
11.14.5 eClinical Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Pharm-Olam
Veristat
ProPharma Group
George Clinical
CRO
Rho, Inc.
CROMSOURCE
SGS
TFS HealthScience
Southern Star Research
Navitas Life Sciences
Celerion
Boyds
eClinical Solutions

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.